Joseph Feingold


Many of life's failures are people who did not realize how close they were to success when they gave up - Thomas Edison

Joseph serves major biopharmaceutical companies, developing strategies for pipeline agents, evaluating commercial opportunities, modeling detailed patient flows and treatment pathways, and optimizing plans for LCM/LOE. His clients span a wide range of therapeutic areas from oncology, cardiology, and hematology, to neurology and rheumatology, in addition to vaccines and diagnostics. Leveraging his experience with both pipeline and established products, prevalent and rare diseases, and US and global markets, Joseph draws upon a diverse problem-solving toolkit to add breadth and depth to his clients’ strategic analysis and planning. Prior to joining Putnam, Joseph founded and led a government-funded venture to develop next-generation alternative energy products. Joseph earned a PhD in Biomedical Engineering from Harvard-MIT, where he specialized in neurophysiology. His published research on novel neural data collection techniques and signal processing in the brain associated with Parkinson’s disease has led to patents for the development of non-invasive diagnostic and monitoring tools for neurological disorders. Joseph earned a Masters of Advanced Study in Mathematics from Cambridge University and graduated magna cum laude from Harvard University with a degree in Physics and Philosophy.

Strategy for the Life Sciences